Novo Nordisk stock jumps 8% as Hims drops $49 semaglutide pill plan

Novo Nordisk climbed 8.3% to 320 Danish crowns in Copenhagen by 10:50 a.m. local time, after Hims & Hers scrapped plans for a $49 weight-loss pill made with compounded semaglutide—the same compound found in Novo’s Wegovy and Ozempic.

9 February 2026

Novo Nordisk Class B stock: what to watch after Hims pulls $49 Wegovy pill copy

Novo Nordisk A/S Class B starts the week with less pressure from copycat concerns, after Hims & Hers said it’s pulling its $49 compounded version of Novo’s Wegovy weight-loss pill. Novo, Hims & Hers, and Eli Lilly are also sinking serious money into Super Bowl ads, all trying to catch more cash-paying U.S. customers.

8 February 2026

CSE:NOVOB.CO·Health News·Pharmaceuticals·Stock Market

Novo Nordisk Class B stock jumps — Wegovy pill scripts and UK dose nod set up the week ahead

Novo Nordisk A/S Class B shares surged 6.49% on Friday, closing at 388.9 Danish crowns after hitting a high of 391.3 crowns during the session. The stock is set to reopen Monday, with traders reacting to the latest Wegovy news.

18 January 2026

CSE:NOVOB.CO·NYSE:LLY·NYSE:NVO·Pharmaceuticals·Stock Market

Novo Nordisk Class B stock rises after Amazon adds Wegovy pill — what to watch before earnings

Novo Nordisk A/S Class B shares rose 3% on Friday after Amazon Pharmacy announced it had started selling the company’s Wegovy weight-loss pill, expanding availability for U.S. patients just days following the drug’s market debut. The Copenhagen-traded stock closed at 381.45 Danish crowns.

10 January 2026

CSE:NOVOB.CO·Pharmaceuticals·Stock Market

Novo Nordisk Class B stock: what to watch after Hims pulls $49 Wegovy pill copy

Novo Nordisk Class B stock jumps — Wegovy pill scripts and UK dose nod set up the week ahead

Novo Nordisk Class B stock rises after Amazon adds Wegovy pill — what to watch before earnings

TechStock² Updates

Intel Stock Falls 2.9% as 14A Defect Gains Confront $2.1 Billion Foundry Loss

Ford Shares Slip 0.5% as Threat of Canada Tariffs Challenges 7.5x Earnings Valuation

Salesforce Shares Lift 1.6% on 2.3x Volume as AI Surge Tests Analyst Price Targets

Nu Shares Drop 3.9%, Wiping Out $2.8 Billion as Fed Uncertainty Clouds Record Earnings

Boeing 777-9 Certification Faces New Labor Risk After $8.4 Billion in Charges

MARA shares drop 10.2%, wiping out $466 million as Bitcoin-backed lending climbs

PayPal Stock Sinks 12.7% as $53 Billion Bid Disappears and Turnaround Takes Over

UiPath Shares Slip 1% with $9.4 Billion Valuation Ahead of September 3 Results

Tenon Medical Shares Edge Down 0.4% as $3 Million Placement Raises Dilution Risk

Solstice Shares Climb 12.8% after $14.5 Billion Tie-Up Collapses, $500 Million Stock Buyback Gets Green Light

Investment Disclaimer